Filing Details

Accession Number:
0001156039-24-000029
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-03-05 16:24:39
Reporting Period:
2024-03-01
Accepted Time:
2024-03-05 16:24:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1156039 Elevance Health Inc. ELV Hospital & Medical Service Plans (6324) 352145715
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1608538 D Peter Haytaian 220 Virginia Avenue
Indianapolis IN 46204
Evp & Pres Carelon & Carelonrx No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-03-01 4,314 $499.11 13,425 No 4 F Direct
Common Stock Acquisiton 2024-03-01 2,405 $0.00 15,830 No 4 A Direct
Common Stock Acquisiton 2024-03-01 9,152 $0.00 24,982 No 4 A Direct
Common Stock Acquisiton 2024-03-04 15,000 $166.97 39,982 No 4 M Direct
Common Stock Disposition 2024-03-04 4,206 $500.18 35,776 No 4 S Direct
Common Stock Disposition 2024-03-04 1,889 $500.18 33,887 No 4 S Direct
Common Stock Disposition 2024-03-04 15,000 $500.18 18,887 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 A Direct
No 4 A Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Acquisiton 2024-03-01 9,280 $0.00 9,280 $499.11
Common Stock Employee Stock Option (Right to Buy) Disposition 2024-03-04 15,000 $0.00 15,000 $166.97
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
9,280 2034-03-01 No 4 A Direct
4,908 2027-03-01 No 4 M Direct
Footnotes
  1. PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
  2. Represents restricted share units. Restrictions lapse as follows:801 shares on 3/1/2025, and 802 shares each on 3/1/2026 and 3/1/2027.
  3. Represents performance based restricted share units. Restrictions lapse on 3/1/2024.
  4. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 4, 2023.
  5. This transaction was executed in multiple trades, each at the same price of $500.18. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares at which the transaction was effected.
  6. The option represents a right to purchase a total of 9,280 shares, and is exercisable in two installments of 3,093 shares each, and one installment of 3,094 shares, beginning on 3/1/2025, which is the one-year anniversary of the option grant date.
  7. The option represents a right to purchase a total of 19,908 shares and is exercisable in six semi-annual installments of 3,318 shares each beginning on 9/1/2017, which is the six-month anniversary of the date on which the option was granted.